Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 1:05 AM
NCT ID:
NCT03045393
Brief Title:
Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Official Title:
Pilot Study of Mirvetuximab Soravtansine (IMGN853) in Folate Receptor Alpha (FRĪ±)-Expressing, Triple Negative Breast Cancer (TNBC) With Residual Disease Post Standard Neoadjuvant Chemotherapy
Acronym:
IMGN853
Study:
NCT03045393
Protocol Section:
NCT03045393